Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Schroder Investment Management Group

Schroder Investment Management Group decreased its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned 206,070 shares of the biotechnology company’s stock after selling 2,490 shares during the quarter. Schroder Investment Management Group’s holdings in Arrowhead Pharmaceuticals were worth $3,835,000 as of its most […]